BioSpace News Archive

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the H.C. Wainwright 25th Annual Global Investment Conference on September 12, 2023 at 3:30pm ET/12:30pm PT.

Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced its participation in the following investor conferences.

Olema Pharmaceuticals, Inc. announced that the Company granted stock options to one new employee to purchase an aggregate of 61,000 shares of the Company’s common stock, effective as of September 1, 2023.

Abbott (NYSE: ABT) and Bigfoot Biomedical today announced a definitive agreement for Abbott to acquire Bigfoot, a leader in developing smart insulin management systems for people with diabetes.

ImmunoGen, Inc. announced that the compensation committee of the Company’s Board of Directors approved, effective as of August 31, 2023, grants of non-qualified stock options to purchase an aggregate of 59,260 shares of its common stock and restricted stock units covering an aggregate of 29,630 shares of its common stock under the Inducement Plan to four new employees.

Zomedica Corp. announced it has completed the acquisition of Structured Monitoring Products, Inc., the makers of the VetGuardian™ touchless vital signs monitoring technology.

TCB Capital Advisors (“TCB” or the “Company”) is thrilled to announce the appointment of Nishant Sachdev as Director, further solidifying its position as a leading healthcare-focused